Posted by Michael Wonder on 21 Aug 2022
Ozempic restrictions for weight loss ‘unfair’, obesity expert says
21 August 2022 - A diabetes drug proven to help with weight loss has been limited for use in diabetics only— but an obesity expert has called on the health regulator to remove the “unfair” restrictions.
In the face of a global shortage, the Therapeutic Goods Administration has recommended Ozempic be prioritised for Type 2 diabetics only, but Professor Joseph Proietto, chair of the Clinical Care Committee of World Obesity, has written to the TGA arguing “the situation is unfair” on obese patients.
